登录

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.

The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by binding to the same receptor. This prevents the agonist drug from activating the receptor and producing its intended effect. For example, naloxone, a competitive antagonist, can block the effects of opioid drugs by binding to opioid receptors and reversing their activation.

In addition, functional or physiological antagonism occurs when a drug binds to a different receptor and produces a physiological response that opposes the effect of the agonist-bound receptor. For example, histamine stimulates acid secretion, while omeprazole prevents acid secretion by inhibiting the proton pump. These drugs can be considered functional antagonists.

Some drugs follow chemical antagonism, which involves the combination of two drugs to form an inactive product. Examples include chelating agents like dimercaprol, which bind to heavy metals and reduce their toxicity. The neutralizing antibody infliximab, which sequesters the inflammatory cytokine tumor necrosis factor (TNF), has an anti-inflammatory effect.

Antagonism can also occur through pharmacokinetic interactions, where one drug affects another drug's absorption, distribution, metabolism, or elimination. For instance, if a drug increases the metabolism or elimination of another drug, it can decrease the concentration and effectiveness of the second drug, leading to antagonistic effects.

Tags
AntagonismDrug InteractionReceptor BindingAllosteric ModulationFunctional InteractionChemical ReactionsPharmacokinetic ProcessesReceptor AntagonismCompetitive AntagonistOpioid ReceptorsPhysiological AntagonismChelating AgentsInfliximabTumor Necrosis Factor TNFDrug Metabolism

来自章节 4:

article

Now Playing

4.14 : Combined Effects of Drugs: Antagonism

Pharmacodynamics

7.5K Views

article

4.1 : 药物作用原则

Pharmacodynamics

5.4K Views

article

4.2 : 药物作用的目标:概述

Pharmacodynamics

5.2K Views

article

4.3 : 信号转导:概述

Pharmacodynamics

8.0K Views

article

4.4 : 换能器机制:G 蛋白偶联受体

Pharmacodynamics

1.6K Views

article

4.5 : 配体门控离子通道受体:门控机制

Pharmacodynamics

1.9K Views

article

4.6 : 换能器机制:酶联受体

Pharmacodynamics

2.2K Views

article

4.7 : 换能器机制:核受体

Pharmacodynamics

1.2K Views

article

4.8 : 剂量-反应关系:概述

Pharmacodynamics

2.7K Views

article

4.9 : 剂量-反应关系:效力和疗效

Pharmacodynamics

3.9K Views

article

4.10 : 剂量-反应关系:选择性和特异性

Pharmacodynamics

6.1K Views

article

4.11 : 治疗指数

Pharmacodynamics

3.8K Views

article

4.12 : 药物-受体相互作用:激动剂

Pharmacodynamics

2.2K Views

article

4.13 : 药物-受体相互作用:拮抗剂

Pharmacodynamics

2.4K Views

article

4.15 : 药物的综合作用:协同作用

Pharmacodynamics

3.0K Views

See More

JoVE Logo

政策

使用条款

隐私

科研

教育

关于 JoVE

版权所属 © 2025 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。